Publication:
Expression of sex hormone-binding globulin, oxytocin receptor, caveolin-1 and p21 in leiomyoma

dc.contributor.authorŞendemir, Aynur
dc.contributor.authorKosmehl, Hartmuth
dc.contributor.authorJirikowsiu, Gustav
dc.contributor.buuauthorŞendemir, Erdoğan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentAnatomi Ana Bilim Dalı
dc.contributor.researcheridAAA-9892-2021
dc.contributor.scopusid6506197826
dc.date.accessioned2022-06-24T06:41:44Z
dc.date.available2022-06-24T06:41:44Z
dc.date.issued2008-02
dc.description.abstractBackground. Interaction of sex hormone-binding globulin (SHBG) and oxytocin (OT) is among the factors that control smooth muscle proliferation and tumor growth through the oxytocin receptor (OTR). Also, a close functional interaction of OTR and caveolin-1 has been shown to modulate cell growth and proliferation. Methods. We studied surgical samples from 23 leiomyoma patients (aged 33-66 years) with immunocytochemistry. Specimens from five patients (34-76 years), who had hysterectomy for other reasons, served as controls. Tissue samples were cut into serial 1-mu m thick sections for co-localization of SHBG, OTR, proliferation marker p21 and caveolin-1. Results. SHBG was found in smooth muscle cells in all samples. OTR staining occurred in most of these cells in myomas, while controls contained only scattered cells positive for OTR. There were no apparent differences in immunostaining for p21, while immunoreactivity for caveolin-1 was observed in most cells in myomas and in only few cells in controls. Caveolin-1 was mostly co-localized with SHBG and OTR in myoma samples whereas controls showed this co-localization only occasionally. Conclusions. Our observations indicate an interaction of SHBG and OTR, associated with caveolin-1, which may account in part for known non-genomic actions of ovarian steroids. Growth of leiomyomas may be linked to these mechanisms.
dc.identifier.citationŞendemir, A. vd. (2008). "Expression of sex hormone-binding globulin, oxytocin receptor, caveolin-1 and p21 in leiomyoma". Gynecological Endocrinology, 24(2), 105-112.
dc.identifier.endpage112
dc.identifier.issn0951-3590
dc.identifier.issn1473-0766
dc.identifier.issue2
dc.identifier.pubmed17952758
dc.identifier.scopus2-s2.0-38349158987
dc.identifier.startpage105
dc.identifier.urihttps://doi.org/10.1080/09513590701690274
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/09513590701690274
dc.identifier.urihttp://hdl.handle.net/11452/27380
dc.identifier.volume24
dc.identifier.wos000253751200010
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherTaylor & Francis
dc.relation.collaborationYurt içi
dc.relation.collaborationYurt dışı
dc.relation.collaborationSanayi
dc.relation.journalGynecological Endocrinology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectEndocrinology & Metabolism
dc.subjectObstetrics & Gynecology
dc.subjectCo-localization
dc.subjectFibroma
dc.subjectOxytocin
dc.subjectOxytocin receptor
dc.subjectp21
dc.subjectSex hormone-binding globulin
dc.subjectMessenger-ribonucleic-acid
dc.subjectUterine leiomyomas
dc.subjectCancer-cells
dc.subjectProliferation
dc.subjectPathogenesis
dc.subjectEndometrium
dc.subjectMyometrium
dc.subjectProtein
dc.subjectGrowth
dc.subjectLocalization
dc.subject.emtreeCaveolin 1
dc.subject.emtreeOxytocin
dc.subject.emtreeOxytocin receptor
dc.subject.emtreeProtein p21
dc.subject.emtreeSex hormone binding globulin
dc.subject.emtreeSeroid hormone
dc.subject.emtreeAdult
dc.subject.emtreeAged
dc.subject.emtreeArticle
dc.subject.emtreeCell proliferation
dc.subject.emtreeCinical article
dc.subject.emtreeControlled study
dc.subject.emtreeDisease marker
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeHuman tissue
dc.subject.emtreeHysterectomy
dc.subject.emtreeImmunocytochemistry
dc.subject.emtreeImmunohistochemistry
dc.subject.emtreeLeiomyoma
dc.subject.emtreePiority journal
dc.subject.emtreeProtein localization
dc.subject.emtreeProtein protein interaction
dc.subject.emtreeProtein secretion
dc.subject.emtreeSmooth muscle fiber
dc.subject.emtreeTumor growth
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshCase-control studies
dc.subject.meshCaveolin 1
dc.subject.meshCyclin-dependent kinase inhibitor p21
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshImmunohistochemistry
dc.subject.meshLeiomyomatosis
dc.subject.meshMiddle aged
dc.subject.meshMyometrium
dc.subject.meshOxytocin
dc.subject.meshReceptors, oxytocin
dc.subject.meshSex hormone-binding globulin
dc.subject.meshUterine neoplasms
dc.subject.scopusSex Hormone-Binding Globulin; Androgen Binding Protein; Odontesthes Bonariensis
dc.subject.wosEndocrinology & metabolism
dc.subject.wosObstetrics & gynecology
dc.titleExpression of sex hormone-binding globulin, oxytocin receptor, caveolin-1 and p21 in leiomyoma
dc.typeArticle
dc.wos.quartileQ4 (Endocrinology & metabolism)
dc.wos.quartileQ3 (Obstetrics & gynecology)
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Anatomi Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: